Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders
Year: 2017
Type: article
Abstract: This Viewpoint summarizes a number of important issues related to the clinical use of ketamine for the treatment of psychiatric disorders addressed in the consensus statement and provides suggestions for addressing remaining concerns.
Source: JAMA
Authors: Samuel T. Wilkinson, Gerard Sanacora
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2746952686
